Miller, Frank RSchool of Medicine |
|
|
Director of Head and Neck Surgery with advanced fellowship training in head and neck oncology, endocrine surgery (thyroid/parathyroid), and skull base surgery; Chairman of Multi-Disciplinary Head and Neck Tumor Board; Deputy Chairman of the Department of Otolaryngology-Head and Neck Surgery. |
|
| 9/2009 - Present | Professor | The University of Texas Health Science Center at San Antonio, Oto-Hns, San Antonio, TX |
| 7/2007 - Present | Deputy Chairman | University of Texas Health Science Center at San Antonio, Oto-Hns, San Antonio, TX |
| 7/2001 - Present | Staff Otolaryngologist | University Health System, Oto-Hns, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 2002 | Clinical Fellowship | Daiichi Clinical Scholars in Evidence Based Med | American Academy of Otolaryngology-Head and Neck Surgery, Inc. Alexandria , VA |
| 1998 | Postdoctoral Fellowship | Head/Neck Oncologic, Skull Base, Laryngology | Vanderbilt University Medical Center Nashville , TN |
| 1994 | Residency | Otolaryngology-Head & Neck Surgery | The Cleveland Clinic Foundation Cleveland , OH |
| 1990 | Internship | General Surgery | The Cleveland Clinic Foundation Cleveland , OH |
| 1989 | MD | Medicine | Brown University School of Medicine Providence , RI |
| 1985 | MS | Exercise Physiology | University of Rhode Island Kingston , RI |
| 1983 | BS | Physical Education | University of Rhode Island Kingston , RI |
Clinical trials in head and neck cancer |
Obstructive sleep apnea |
Outcomes research in Otolaryngology |
Role PET imaging head neck cancer |
Supraspinal accessory lymph node metastases- (level 1-B) in squamous cell carcinoma of the head and neck |
Targeted tumor diagnostic imaging and radionuclide |
Thyroid - parathyroid surgery |
Zenkers Diverticulum |
| Date | Description | Institution | # Students |
| 7/2012 - 6/2013 | Otorhinolaryngology Research | The University of Texas Health Science Center | |
| 5/2012 - Present | Individual Instruction | UTHSCSA | |
| 3/2012 - Present | Individual Instruction | UTHSCSA | |
| 9/2011 - Present | Individual Instruction | UTHSCSA | |
| 7/2010 - Present | Head and Neck Oncology Monthly Seminar Series for Residents | UTHSCSA | 10 students |
| 7/2001 - Present | Operating Room | University Hlth Care System and Audie Murphy Veterans Hospital | |
| 7/2001 - Present | Clinics | University Hlth Care System and Audie Murphy Veterans Hospital | |
| 7/2001 - Present | Wards | University Hlth Care System and Audie Murphy Veterans Hospital | |
Journal Article |
| King JM, Corbitt C, Miller FR. Management of lateral cervical metastases in papillary thyroid cancer; pattern of lymph node distribution ENT Journal 2011 Aug;90:386-389. |
| Eid I, Miller FR, Rowan S, Otto RA. The role of nerve monitoring to predict post-operative recurrent laryngeal nerve function in thyroid and parathyroid surgery Laryngoscope 2011 Jan;121:S276-S276. |
| Graff AT, Miller FR, Roehm CE, Prihoda TJ. Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs. serial calcium levels Ear Nose Throat J 2010 Sep;89(9):462-465. |
| Weigum SE, Floriano PN, Redding SW, Yeh CK, Westbrook SC, McGuff HS, Lin A, Miller FR, Villarreal F, Rowan SD, Vigneswaran N, Williams MD, McDevitt JT. Nano-Bio-Chip Sensor Platform For Examination of Oral Exfolliative Cytology Cancer Prev Res 2010 Apr;3(4):518-528. |
| Weigum SE, Floriano PN, Redding SW, Yeh C, McGuff HS, Lin A, Miller FR, Villarreal AD, Vigneswaran N, Williams MD, Richards-Kortum R, McDevitt JT. Lab-on-a-chip sensor for analysis of cellular biomarkers in oral exfoliative cytology: a new diagnostic tool for early detection of oral cancer Neoplasia 2009 Apr;2009. |
| Wang SX, Bao A, Phillip WT, Goins B, Herrera SJ, Santoyo C, Miller FR, Otto RA. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model Int J Pharm 2009 Feb;373(1-2). |
| Wang SX, Bao A, Herrera SJ, Phillips WT, Goins B, Santoyo C, Miller FR, Otto RA. Intraoperative 186Re-Liposome Radionuclide Therapy in a Head and Neck Squamous Cell Carcinoma Xenograft Positive Surgical Margin Model Clin Cancer Res 2008 Jun;14(12):3975-3983. |
| Miller FR, Karnad AB, Eng TY, Hussey DH, McGuff HS, Otto RA. Management of the Unknown Primary Carcinoma: Long-term Follow-up on a Negative PET Scan and Negative Panendoscopy Head & Neck 2008 Jan;1:28-34. |
| Stallworth C, McMains KC, Miller FR. Complicated community acquired MRSA sinusitis Otolaryngo Head Neck Surg 2008 Jan;139:120-121. |
Book Chapter |
| Couch M, Herrington H, Miller FR. Nutrition, Fluid, Electrolytes. In: Couch M, Herrington H, Miller F. Essential Otolaryngology Head Neck Surgery. New York City: McGraw Hill Company; 2012. p. 920-930. |
Federal |
|
| Funding Agency | NIH/NCI |
| Title | EGFR antisense DNA added to cetuximab and radiotherapy for head and neck cancer |
| Status | Active |
| Period | 9/2008 - 8/2011 |
| Role | Co-Investigator |
| Grant Detail | The overall goal of this R21 is to further investigate EGFR AS in the setting of potentially curable SCCHN. Our central hypothesis is that dual EGFR targeting with EGFR AS and cetuximab will result in improve locoregional control and other efficacy parameters when combined with radiation therapy for the treatment of locally advanced SCCHN. |